Research Papers:
Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells
Metrics: PDF 1911 views | HTML 3290 views | ?
Abstract
Cefan Zhou1,2,*, Hongxia Cheng3,*, Wenying Qin1,*, Yi Zhang1, Hui Xiong4, Jing Yang5, Huang Huang1, Yefu Wang2, Xing-Zhen Chen1,6, Jingfeng Tang1
1Institute of Biomedical and Pharmaceutical Sciences, Key Laboratory of Fermentation Engineering (Ministry of Education), College of Bioengineering, Hubei University of Technology, Wuhan, 430068, China
2The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China
3Department of Chemical and Pharmaceutical Engineering, Wuhan Huaxia University of Technology, Wuhan, 430223, China
4XiLi People's Hospital, Shenzhen, Guangdong, 518055, China
5Institute for Immunology, Tsinghua University, Beijing, 100084, China
6Membrane Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2R3, Canada
*These authors contributed equally to this work
Correspondence to:
Jingfeng Tang, email: [email protected]
Keywords: Pygo2, paclitaxel, MDR1, P-glycoprotein, glioma
Received: November 16, 2016 Accepted: February 20, 2017 Published: March 02, 2017
ABSTRACT
Anti-microtubule drugs, such as paclitaxel (PTX), are extensively used for the treatment of numerous cancers. However, growing evidence has shown that PTX resistance, either intrinsic or acquired, frequently occurs in patients and results in the failure of treatment, contributing to the high cancer mortality rate. Therefore, it is necessary to identify the genes or pathways involved in anti-microtubule drug resistance for future successful treatment of cancers. Pygopus2 (Pygo2), which contains a Zn-coordinated plant homeodomain (PHD) finger domain, is critical for β-catenin-dependent transcriptional switches in normal and malignant tissues and is over-expressed in various cancers, including human brain glioma. In this study, we report that over-expression of Pygo2 inhibited the efficacy of PTX and contributed to cell multidrug resistance in two different ways. First, over-expression of Pygo2 inhibited the PTX-induced phosphorylation of B-cell lymphoma 2 (Bcl-2), suppressing the proteolytic cleavage of procaspase-8/9 and further inhibiting the activation of caspase-3, which also inhibits the activation of the JNK/SAPK pathway, ultimately inhibiting cell apoptosis. Second, over-expression of Pygo2 facilitated the expression of P-glycoprotein, which acts as a drug efflux pump, by promoting the transcription of Multi-drug resistance 1 (MDR1) at the MDR1 promoter loci, resulting in acceleration of the efflux of PTX.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15843